The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Paroxetine Treatment of Generalized Social Phobia (Social Anxiety Disorder): A Randomized Controlled Trial
Abstract
CONTEXT: The generalized type of social phobia (social anxiety disorder) is a severe and often disabling form of social anxiety that affects approximately 5% of the general population. Earlier research has shown monoamine oxidase inhibitors or benzodiazepines to be effective in treating this condition, but neither has achieved widespread use. OBJECTIVE: To compare the efficacy of paroxetine, a selective serotonin reuptake inhibitor, with placebo in adults with generalized social phobia. DESIGN: Twelve-week, multicenter, randomized, double-blind trial. SETTING: Thirteen centers across the United States and 1 in Canada. PARTICIPANTS: Between April 13, 1995, and February 28, 1996, 187 persons meeting Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for generalized social phobia were randomized (and 183 returned for at least 1 efficacy assessment) to treatment. INTERVENTION: After a 1-week, single-blind, placebo, run-in period, patients received a double-blind, 11-week course of either paroxetine or matching-image placebo. The initial daily dosage of paroxetine (or placebo) was 20 mg with increases of 10 mg/d weekly (flexible dosing to a maximum of 50 mg/d) permitted after the second week of treatment. MAIN OUTCOME MEASURES: Number of responders based on the Clinical Global Impression Global Improvement Item ("much improved" or "very much improved"); mean change from baseline on the Liebowitz Social Anxiety Scale total score. RESULTS: Fifty (55.0%) of 91 persons taking paroxetine and 22 (23.9%) of 92 persons taking placebo were much improved or very much improved at the end of treatment (odds ratio [OR], 3.88; 95% confidence interval [CI], 2.81-5.36). Mean Liebowitz Social Anxiety Scale total scores were reduced by 39.1% (the mean baseline score of 78.0 declined by a mean of 30.5 points at follow-up) in the paroxetine group compared with 17.4% (the mean baseline score of 83.5 declined 14.5 points at follow-up) in the placebo group, a difference of 21.7% (95% CI, 8.7%-34.7%) favoring paroxetine. CONCLUSIONS: Paroxetine is an effective treatment for patients with generalized social phobia. Short-term (ie, 11-week) treatment results in substantial and clinically meaningful reductions in symptoms and disability. Future research should test whether these may be further reduced by extended treatment or supplementation with specific educational-cognitive-behavioral techniques.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Measurement of social-evaluative anxiety.
Watson, D., & Friend, R. (1969) · Journal of Consulting and Clinical Psychology · doi:10.1037/h0027806 · Cited by 3,467
Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.272.22.1749 · Cited by 2,635
Schneier (1992) · doi:10.1001/archpsyc.1992.01820040034004 · Cited by 1,142
Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey
Magee, W. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020077009 · Cited by 996
Spitzer, R. L. (1995) · JAMA · doi:10.1001/jama.274.19.1511 · Cited by 684
Social Phobia: Review of a Neglected Anxiety Disorder
Liebowitz, M. R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790300097013 · Cited by 577
Self-citationFunctional impairment in social phobia.
Schneier, F. R., Heckelman, L., Garfinkel, R. S., Campeas, R. B., Fallon, B. A., Gitow, A., Street, L. L., Bene, D. D., & Liebowitz, M. R. (1994) · PubMed · Cited by 534
Self-citationPhenelzine vs Atenolol in Social Phobia: A Placebo-Controlled Comparison
Liebowitz, M. R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., Fyer, A., Gorman, J., Papp, L., Davies, S., Gully, R., et al. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.49.4.290 · Cited by 444
Self-citationSocial Phobia Subtypes in the National Comorbidity Survey
Kessler, R. C., Stein, M. B., & Berglund, P. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.5.613 · Cited by 398
Self-citationMeta-analysis of cognitive-behavioral treatments for social phobia
Taylor, S. (1996) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(95)00058-5 · Cited by 374
Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.
Cohn, C. K., Shrivastava, R., Mendels, J., Cohn, J. B., Fabre, L. F., Claghorn, J. L., Dessain, E. C., Itil, T. M., & Lautin, A. (1990) · PubMed · Cited by 348
One-Year Prevalence of Psychiatric Disorder in Ontarians 15 to 64 Years of Age
Offord, D. R., Boyle, M. H., Campbell, D., Goering, P., Lin, E., Wong, M., & Racine, Y. A. (1996) · The Canadian Journal of Psychiatry · doi:10.1177/070674379604100904 · Cited by 337
Assessing impairment in patients with panic disorder: the Sheehan Disability Scale
Leon, A. C., Shear, M. K., Portera, L., & Klerman, G. L. (1992) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00788510 · Cited by 319
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.408 · Cited by 270
van Vliet, I. M., den Boer, J. A., & Westenberg, H. G. M. (1994) · Psychopharmacology · doi:10.1007/bf02244762 · Cited by 269
Treatment of Social Phobia With Clonazepam and Placebo
DAVIDSON, J. R. T., POTTS, N., RICHICHI, E., KRISHNAN, R., FORD, S. M., SMITH, R., & WILSON, W. H. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199312000-00008 · Cited by 265
Stein, M. B. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020087010 · Cited by 259
Self-citationSchonfeld, W. H., Verboncoeur, C. J., Fifer, S. K., Lipschutz, R. C., Lubeck, D. P., & Buesching, D. P. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(96)01416-4 · Cited by 247
Sertraline for social phobia: a double-blind, placebo-controlled crossover study
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1368 · Cited by 238
Social phobia in general health care: an unrecognised undertreated disabling disorder
Weiller, E., Bisserbe, J. C., Boyer, P., Lepine, J. P., & Lecrubier, Y. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.168.2.169 · Cited by 219
Medication therapy for social phobia.
Marshall, R. D., Schneier, F. R., Fallon, B. A., Feerick, J., & Liebowitz, M. R. (1994) · PubMed · Cited by 218
Self-citationSocial phobia: a pharmacologic treatment overview.
Jefferson, J. W. (1995) · PubMed · Cited by 184
Untreated Anxiety Among Adult Primary Care Patients in a Health Maintenance Organization
Fifer, S. K. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950090072010 · Cited by 179
Noyes, R., Moroz, G., Davidson, J. R. T., Liebowitz, M. R., Davidson, A. B., Siegel, J., Bell, J., Cain, J. W., Curlik, S. M., Kent, T. A., et al. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199708000-00002 · Cited by 150
Self-citationStein, M. B., Chartier, M., Hazen, A. L., Kroft, C. D. L., Chale, R. A., Cote, D. D., & Walker, J. R. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199606000-00005 · Cited by 139
Self-citationContemporary management of depression
Andrews, J., & Nemeroff, C. B. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90360-3 · Cited by 120
Wilde, J. D., Spiers, R., Mertens, C., Bartholomé, F., Schotte, G., & Leyman, S. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03345.x · Cited by 111
Moclobemide in social phobia: A double-blind, placebo-controlled clinical study
Katschnig, H. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900196 · Cited by 111
Fluoxetine for the Treatment of Social Phobia
BLACK, B., Uhde, T. W., & Tancer, M. E. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199208000-00022 · Cited by 106
Fluoxetine efficacy in social phobia.
Ameringen, M. V., Mancini, C., & Streiner, D. L. (1993) · PubMed · Cited by 101
Recent developments in the psychopharmacology of anxiety disorders.
Lydiard, R. B., Brawman‐Mintzer, O., & Ballenger, J. C. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.4.660 · Cited by 89
Self-citationTreatment of generalized social phobia: Results at long-term follow-up
Scholing, A., & Emmelkamp, P. M. G. (1996) · Behaviour Research and Therapy · doi:10.1016/0005-7967(96)00010-1 · Cited by 68
Schneier, F. R., Chin, S. J., Hollander, E., & Liebowitz, M. R. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199202000-00018 · Cited by 68
Self-citationFluoxetine Treatment of Social Phobia
Sternbach, H. A. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199006000-00024 · Cited by 55
Stein, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90604-2 · Cited by 48
Self-citationSocial phobia: epidemiology, recognition, and treatment
den Boer, J. A. (1997) · BMJ · doi:10.1136/bmj.315.7111.796 · Cited by 48
Pharmacotherapy of social phobia.
Domenici, N., & Griffin-Francell, C. (1993) · PubMed · Cited by 20
Social phobia: diagnostic issues and review of cognitive behavioral treatment strategies.
Juster, H. R., Rg, H., & Cs, H. (1996) · PubMed · Cited by 18
Berk, M. (1995) · PubMed · Cited by 4
(1996) · doi:10.1002/(sici)1520-6394(1996)4:3<126::aid-da5>3.0.co;2-e
Cited by
Stein, M. B., & Stein, D. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60488-2 · Cited by 1,137
Self-citationKatzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
FRESCO, D. M., COLES, M. E., HEIMBERG, R. G., LIEBOWITZ, M. R., HAMI, S., STEIN, M. B., & GOETZ, D. (2001) · Psychological Medicine · doi:10.1017/s0033291701004056 · Cited by 874
Self-citationBandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
The Liebowitz social anxiety scale as a self-report instrument: a preliminary psychometric analysis
Baker, S. L., Heinrichs, N., Kim, H.-J., & Hofmann, S. G. (2002) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(01)00060-2 · Cited by 640
Metadata
- Authors
- Stein, M. B., Liebowitz, M. R., Lydiard, R. B., Pitts, C. D., Bushnell, W., & Gergel, I.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1998-08-26
- Volume
- 280
- Issue
- 8
- Pages
- 708
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1994095895
- Cited by
- 348
- References
- 42
- FWCI
- 56.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.